In the TCGA database, we discovered that S100A16 expression was elevated in RCC, and individuals with RCC and high S100A16 expression levels had lower OS, DSS, and PFI than those with low S100A16 expression levels. This evidence concerns the gene S100A16 and renal cell adenocarcinoma.